Melanoma is the most life threatening form of skin cancer, the
incidence of which has been rising in the developing world due to
its link with sun exposure. The increase in incidence had made it
imperative that clinicians managing these patients keep up-to-date
with the latest advances, allowing them to provide optimal
treatment.
As with the other Challenges books, Challenges in
Melanoma assumes a certain level of knowledge and builds on
this by discussing only areas of controversy and uncertainty in the
basic science and clinical management of the disease. Authors aim
to provide a balanced answer based on the scientific evidence, but
ultimately draw some conclusions that will be of relevance to
clinical practice.
The content is organised into three sections: aetiology; diagnosis,
screening and prevention; and management. All the chapters ask
practical and pertinent questions. The book takes a global view of
melanoma as a public health risk as well as looking at management
issues.
Cuprins
Aetiology and Risk.
Chapter 1: What patterns of sun exposure really cause
melanoma?.
Chapter 2: Are sunbeds dangerous?.
Chapter 3: Do sunscreens cause cancer or protect from a risk of
melanoma?.
Chapter 4: Why are redheads so susceptible to melanoma?.
Chapter 5: How should we manage patients with atypical
moles?.
Chapter 6: What should we know and what should we do about
high-risk families?.
Chapter 7: How should we manage borderline melanocytic
lesions?.
.
Diagnosis, Screening and Prevention.
Chapter 8: How can we improve early diagnosis?.
Chapter 9: What are the prospects for screening for melanoma at
different latitudes?.
.
Management.
Chapter 10: What should we consider when excising the
primary?.
Chapter 11: What imaging/investigation in melanoma
patients?.
Chapter 12: What management for regional lymph node
relapse?.
Chapter 13: What are the issues surrounding congenital
naevi?.
Chapter 14: What is the role of chemotherapy?.
Chapter 15: What is the role of biological-response-modifiers in
the treatment of melanoma?.
Chapter 16: Will vaccines really work for melanoma?.
Chapter 17: Who should we consider for isolated limb
perfusion?.
Chapter 18: What are the novel treatment strategies are on the
horizon?.
Chapter 19: Who should follow-up melanoma patients and for how
long?.
Chapter 20: What is the role for radiotherapy in melanoma?.
Chapter 21: What should we tell patients about hormones after
having melanoma?
Despre autor
Julia A. Newton Bishop is the editor of Melanoma: Critical Debates, published by Wiley.
Martin Gore is the editor of Melanoma: Critical Debates, published by Wiley.
Mai multe cărți electronice de la același autor (i) / Editor
144.005 Ebooks din această categorie
